Cargando…
Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
Paracoccidioidomycosis is a neglected disease that causes economic and social impacts, mainly affecting people of certain social segments, such as rural workers. The limitations of antifungals, such as toxicity, drug interactions, restricted routes of administration, and the reduced bioavailability...
Autores principales: | do Carmo Silva, Lívia, de Oliveira, Amanda Alves, de Souza, Dienny Rodrigues, Barbosa, Katheryne Lohany Barros, Freitas e Silva, Kleber Santiago, Carvalho Júnior, Marcos Antonio Batista, Rocha, Olívia Basso, Lima, Raisa Melo, Santos, Thaynara Gonzaga, Soares, Célia Maria de Almeida, Pereira, Maristela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712482/ https://www.ncbi.nlm.nih.gov/pubmed/33228010 http://dx.doi.org/10.3390/jof6040300 |
Ejemplares similares
-
Dermatology: Where are We Coming from and Where are We Going to?
por: van de Kerkhof, Peter C. M.
Publicado: (2014) -
The peritumoral brain zone in glioblastoma: where we are and where we are going
por: Giambra, Martina, et al.
Publicado: (2022) -
Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
por: José da Silva Domingos, Iago, et al.
Publicado: (2021) -
Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009) -
The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)